SIENTRA SILICONE GEL BREAST IMPLANTS
Tiger Aesthetics Medical, LLC · Decision date Mar 9, 2012
What did the FDA approve?
FDA records P070004 as an original PMA application. The recorded decision is approval, dated Mar 9, 2012.
FDA approval order statement
APPROVAL FOR THE SIENTRA SILICONE GEL BREAST IMPLANTS. THIS DEVICE IS INDICATED FOR: 1) BREAST AUGMENTATION FOR WOMEN AT LEAST 22 YEARS OLD. BREAST AUGMENTATION INCLUDES PRIMARY BREAST AUGMENTATION AS WELL AS REVISION SURGERY TO CORRECT OR IMPROVE THE RESULT OF PRIMARY BREAST AUGMENTATION SURGERY; AND 2) BREAST RECONSTRUCTION. BREAST RECONSTRUCTION INCLUDES PRIMARY RECONSTRUCTION TO REPLACE BREAST TISSUE THAT HAS BEEN REMOVED DUE TO CANCER OR TRAUMA OR THAT HAS FAILED TO DEVELOP PROPERLY DUE TO A SEVERE BREAST ABNORMALITY. BREAST RECONSTRUCTION ALSO INCLUDES REVISION SURGERY TO CORRECT OR IMPROVE THE RESULTS OF A PRIMARY BREAST RECONSTRUCTION SURGERY.
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Mar 9, 2012
Regulatory record facts
- Identifier
- P070004
- Regulatory pathway
- Premarket approval application
- Applicant
- Tiger Aesthetics Medical, LLC
- Product code
- FTR
- Decision code
- APPR
- Decision date
- Mar 9, 2012
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.
- Applicant
- Tiger Aesthetics Medical, LLC
- Product code
- FTR
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P070004 received
Application receipt date recorded by FDA.
P070004 · FDA decision
APPR
P070004/S049 · Related supplement
Sientra Silicone Gel Breast Implants
Timeline entries are records held by MedtechLedger for P070004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P070004
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Sientra Silicone Gel Breast ImplantsP070004/S049 | Tiger Aesthetics Medical, LLC | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code FTR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MemoryGel Breast ImplantsP030053/S093 | Mentor Corp. | PMA supplement | Oct 23, 2026 | FDA |
MemoryShape Breast ImplantsP060028/S063 | Mentor Worldwide, LLC | PMA supplement | Oct 23, 2026 | FDA |
| Motiva USA, LLC | PMA supplement | Oct 2, 2026 | FDA | |
| Allergan | PMA supplement | Sep 29, 2026 | FDA | |
| Motiva USA, LLC | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tiger Aesthetics Medical, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9779 S. Franklin Dr., Suite 300, Franklin, WI, 53132
Sources and methodology
- Original FDA record: P070004
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



